Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645862 · ClinicalTrials.gov registry record
Prospective 4D CTA of BAV Competence
A clinical trial of Bicuspid, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04645862: Recruiting study of Bicuspid, sponsored by University of Pennsylvania.
NCT04645862 is a study of Bicuspid that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04645862, a study of Bicuspid, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The study involves annual 4D CTA imaging of the bicuspid aortic valve for a period of 5 years. CTA is often standard of care for BAV patients, but patients in this study will receive a higher radiation dose with a 4D imaging protocol. There may also be patients enrolled in the study who have a 4D CTA for research purposes when a routine CTA is not required for clinical care.
Primary Outcome
Surface area of each cusp in mm2 in one cardiac cycle (\~0.6 - 1s in length). This measurement is made directly from the CT image.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT scans
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2027-12-31 |
What NCT04645862 shows while recruiting
NCT04645862 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Bicuspid appearing as the primary indexed condition, and to 1 intervention - of which CT scans is the first listed.
NCT04645862 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04645862 about?
NCT04645862 is a clinical study titled "Prospective 4D CTA of BAV Competence". The study involves annual 4D CTA imaging of the bicuspid aortic valve for a period of 5 years. CTA is often standard of care for BAV patients, but patients in this study will receive a higher radiation dose with a 4D imaging protocol. There may also be patients enrolled in the study who have a 4D CT...
What is the current status of trial NCT04645862?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2020-12-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04645862 study?
This clinical trial studies the following conditions: Bicuspid.
What interventions are being tested in trial NCT04645862?
The interventions under investigation include: CT scans (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04645862?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04645862 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI